CLSD logo

Clearside Biomedical (CLSD)

Profile

Full Name

Clearside Biomedical, Inc.

Ticker Symbol

CLSD

Exchange

NASDAQ

Country

United States

IPO

June 2, 2016

Indexes

Not included

Employees

32

Key Details

Price

$0.85(+3.37%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.66M(-79.77% YoY)

Annual EPS

-$0.47(+11.32% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 8, 25 Needham
Buy
Mar 31, 25 HC Wainwright & Co.
Buy
Mar 28, 25 Needham
Buy
Mar 28, 25 Citizens Capital Markets
Market Outperform
Mar 28, 25 Chardan Capital
Buy
Mar 6, 25 Needham
Buy
Mar 6, 25 HC Wainwright & Co.
Buy
Nov 15, 24 Chardan Capital
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Nov 13, 24 Needham
Buy

Institutional Ownership

  • What is the ticker symbol for Clearside Biomedical?
  • Does Clearside Biomedical pay dividends?
  • What sector is Clearside Biomedical in?
  • What industry is Clearside Biomedical in?
  • What country is Clearside Biomedical based in?
  • When did Clearside Biomedical go public?
  • Is Clearside Biomedical in the S&P 500?
  • Is Clearside Biomedical in the NASDAQ 100?
  • Is Clearside Biomedical in the Dow Jones?
  • When was Clearside Biomedical's last earnings report?
  • When does Clearside Biomedical report earnings?
  • Should I buy Clearside Biomedical stock now?

What is the ticker symbol for Clearside Biomedical?

The ticker symbol for Clearside Biomedical is NASDAQ:CLSD

Does Clearside Biomedical pay dividends?

No, Clearside Biomedical does not pay dividends

What sector is Clearside Biomedical in?

Clearside Biomedical is in the Healthcare sector

What industry is Clearside Biomedical in?

Clearside Biomedical is in the Biotechnology industry

What country is Clearside Biomedical based in?

Clearside Biomedical is headquartered in United States

When did Clearside Biomedical go public?

Clearside Biomedical's initial public offering (IPO) was on June 2, 2016

Is Clearside Biomedical in the S&P 500?

No, Clearside Biomedical is not included in the S&P 500 index

Is Clearside Biomedical in the NASDAQ 100?

No, Clearside Biomedical is not included in the NASDAQ 100 index

Is Clearside Biomedical in the Dow Jones?

No, Clearside Biomedical is not included in the Dow Jones index

When was Clearside Biomedical's last earnings report?

Clearside Biomedical's most recent earnings report was on Mar 27, 2025

When does Clearside Biomedical report earnings?

The next expected earnings date for Clearside Biomedical is May 9, 2025

Should I buy Clearside Biomedical stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page